es·tra·mus·tine

(ĕs′trə-mŭs′tēn′)

A drug, C₂₃H₃₁Cl₂NO₃, that combines the actions of estrogen and nitrogen mustard in the treatment of prostate cancer.

American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

References in periodicals archive

Lexi Pharma team members have collectively filed 15 New Drug Applications and have been involved in the development and launch of successfully marketed products including: Byetta, Bydureon, Camptosar, Dacogen, Ellence, Emcyt, Erbitux, Folotyn, Panretin, Symlin, Sutent, Targretin, Vidaza, Velcade, and Zarnestra.

Altum Pharmaceuticals Closes Acquisition of Bone Disease and Oncology Specialist Lexi Pharma

A parallel study comparing Taxotere and estramustine (Emcyt), an antineoplastic compound that contains estradiol and is approved for prostate cancer, to mitoxantrone and prednisone found about a 1.9 month survival advantage for the patients receiving Taxotere, said Dr.

Taxotere (with prednisone)

* For men with hormone-refractory prostate cancer, the use of docetaxel (Taxotere, Rhone-Poulenc Rorer) plus the nitrogen mustard estramustine phosphate (Emcyt, Pharmacia & Upjohn) appears to help men whose prostate cancers no longer respond to treatment with synthetic estrogen and antiandrogens.

Results of breast cancer rugs under spotlight

All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.